BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 24603851)

  • 1. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
    Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
    Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling.
    Wang GP; Han XF
    Mol Med Rep; 2015 Jul; 12(1):1381-6. PubMed ID: 25760022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
    Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
    Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
    Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
    Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H
    Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
    Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
    Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling.
    Li J; Zheng Y; Sun G; Xiong S
    Oncol Rep; 2014 Dec; 32(6):2511-6. PubMed ID: 25334070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo.
    Wang W; Dai LX; Zhang S; Yang Y; Yan N; Fan P; Dai L; Tian HW; Cheng L; Zhang XM; Li C; Zhang JF; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
    Neoplasma; 2013; 60(3):274-83. PubMed ID: 23373996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-Targeted Knockdown of miR-21 and CXCR4 Inhibits Malignant Glioma Progression by Suppression of the PI3K/AKT and Raf/MEK/ERK Pathways.
    Liu F; Yang B
    Biomed Res Int; 2020; 2020():7930160. PubMed ID: 33123586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
    Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
    Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
    Ji Y; Sun Q; Zhang J; Hu H
    Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.